AbCellera Biologics Inc. (ABCL)

NASDAQ: ABCL · Real-Time Price · USD

2.48

-0.01 (-0.40%)

At close: May 02, 2025, 2:23 PM

AbCellera Biologics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-162.86M	-146.4M	158.52M	153.46M	118.92M	-2.21M	309K
Depreciation & Amortization	90.85M	30.89M	33.1M	17.25M	5.27M	1.85M	918K
Stock-Based Compensation	67.58M	64.18M	49.48M	30.65M	8.4M	890.23K	615K
Other Working Capital	n/a	56.01M	51.47M	36.74M	16.51M	3.78M	3.11M
Other Non-Cash Items	-104.13M	-7.74M	8.55M	3.57M	4.71M	194.19K	-188K
Deferred Income Tax	n/a	1.96M	-2.11M	-2.02M	2.1M	n/a	n/a
Change in Working Capital	n/a	13.22M	29.82M	41.67M	-116.7M	1.97M	1.91M
Operating Cash Flow	-108.56M	-43.88M	277.36M	244.58M	22.69M	2.69M	3.56M
Capital Expenditures	-78.4M	-77.51M	-72.66M	-58.45M	-14.67M	-4M	-5.31M
Cash Acquisitions	n/a	-13.69M	-25.68M	-41.78M	-106.89M	n/a	n/a
Purchase of Investments	-765.09M	-1.07B	-781.35M	-292.24M	-19.25M	n/a	n/a
Sales Maturities Of Investments	n/a	910.94M	510.63M	27.61M	19.25M	n/a	n/a
Other Investing Acitivies	964.89M	25.31M	16.43M	32.62M	1.78M	-1.78M	n/a
Investing Cash Flow	121.41M	-221.11M	-352.63M	-332.25M	-119.78M	-5.78M	-5.31M
Debt Repayment	n/a	11.59M	2.75M	5.49M	85.15M	180.66K	1.98M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	-11.15K	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	12.77M	-1.23M	-4.38M	-9.37M	598.5M	174.00	37K
Financial Cash Flow	12.77M	10.36M	-1.63M	-3.89M	683.65M	194.83K	12.19M
Net Cash Flow	23M	-254.04M	-86.49M	-92.97M	586.56M	-2.89M	10.44M
Free Cash Flow	-186.95M	-121.38M	204.7M	186.13M	8.02M	-1.3M	-1.74M